# Acute Liver Injury Following Herbal Drink Consumption With Steatosis and Immune Activation: A Case Report

**Authors:** Helai Hussaini, Aiman Waheed, Olaniyi Fadeyi, Antoine Boustany, Yusuke Hashimoto, Andrew T Flint

PMC · DOI: 10.7759/cureus.79839 · Cureus · 2025-02-28

## TL;DR

A 32-year-old man developed acute liver injury after consuming a herbal drink, showing elevated liver enzymes and immune activation.

## Contribution

This case report highlights the liver toxicity risk of polyherbal remedies and emphasizes early detection for preventing complications.

## Key findings

- The patient showed severe liver damage with AST 1,043 U/L and ALT 1,645 U/L after herbal drink consumption.
- Elevated IgG levels indicated immune activation as a possible mechanism for the liver injury.
- The patient improved with supportive care, but the case underscores the risks of herbal remedies.

## Abstract

Herbal medicines are widely used for their perceived health benefits; however, their potential for liver toxicity is well-documented. We report a case of acute liver injury (ALI) in a 32-year-old male patient following the consumption of a multi-herbal drink. The patient, with a history of cholecystectomy for gallstones and nephrolithiasis, presented with severe epigastric pain radiating to the right shoulder, nausea, high blood pressure (170/113 mmHg), and a rapid heart rate. Laboratory tests revealed significant liver damage, with aspartate aminotransferase (AST) at 1,043 U/L, alanine aminotransferase (ALT) at 1,645 U/L, and total bilirubin at 4.8 mg/dL. Ultrasound imaging showed fatty liver disease without bile duct obstruction. Autoimmune testing was negative for antinuclear antibodies (ANA) and antimitochondrial antibodies (AMA), while elevated immunoglobulin G (IgG) levels suggested immune activation as a potential mechanism. The patient improved with supportive care. This case highlights the potential liver toxicity of polyherbal remedies and underscores the importance of early recognition and management to prevent long-term complications.

## Linked entities

- **Diseases:** fatty liver disease (MONDO:0004790), gallstones (MONDO:0005346), nephrolithiasis (MONDO:0008171)

## Full-text entities

- **Genes:** GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}
- **Diseases:** gallstones (MESH:D042882), epigastric pain (MESH:D010146), nephrolithiasis (MESH:D053040), nausea (MESH:D009325), Steatosis (MESH:D005234), bile duct obstruction (MESH:D002779), ALI (MESH:D017114), liver damage (MESH:D056486)
- **Chemicals:** bilirubin (MESH:D001663), Herbal Drink (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11955213/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11955213/full.md

## References

17 references — full list in the complete paper: https://tomesphere.com/paper/PMC11955213/full.md

---
Source: https://tomesphere.com/paper/PMC11955213